Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir plus Fufang Biejia Ruangan tablets for hepatitis B-related liver fibrosis
ChiCTR-TRC-13003581Phase 4Completed
- Sponsor
- 302 Hospital of the People's Liberation Army
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of entecavir and Fufang Biejia Ruangan in hepatic fibrosis and Chronic Hepatitis B (CHB) (2 arms), sponsored by 302 Hospital of the People's Liberation Army. Primary endpoints: Liver histological changes, Three routine examinations and 3 more. Started Oct 2013; status: completed.
02
Drugs
entecavirFufang Biejia Ruangan
03
Conditions
hepatic fibrosisChronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-13003581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003581.